Officer pay: Tan, Bo (1973) 譚擘

Tan, Bo (1973) 譚擘

Click on "Organisation" or "Year-end" to sort by firm or year. Click on the date to see all the pay of the organisation for that year.

Organisation	Last position	Year-end	Fees	Salary & benefits	Bonus	Retire	Share- based	Total
2023 HKD'000
Akeso, Inc.	INED	2023-12-31	358					358
Everest Medicines Limited	INED	2023-12-31					-166	-166
HighTide Therapeutics, Inc.	INED	2023-12-31	5					5
Total			363	0	0	0	-166	197
2022 HKD'000
Akeso, Inc.	INED	2022-12-31	338					338
Everest Medicines Limited	INED	2022-12-31	376				305	681
Total			714	0	0	0	305	1,019
2021 HKD'000
Akeso, Inc.	INED	2021-12-31	355					355
Everest Medicines Limited	INED	2021-12-31	394				471	865
Total			749	0	0	0	471	1,220
2020 HKD'000
Akeso, Inc.	INED	2020-12-31	253					253
Everest Medicines Limited	INED	2020-12-31	109					109
Total			362	0	0	0	0	362
2019 HKD'000
3SBio Inc.	FD, VP	2019-12-31	2,472	410		240	405	3,527
Total			2,472	410	0	240	405	3,527
2018 HKD'000
3SBio Inc.	FD, VP	2018-12-31	4,439	549		228	657	5,872
Total			4,439	549	0	228	657	5,872
2017 HKD'000
3SBio Inc.	FD, VP	2017-12-31	2,576	577		223	836	4,213
Total			2,576	577	0	223	836	4,213
2016 HKD'000
3SBio Inc.	FD, VP	2016-12-31	2,706	578		189		3,472
Total			2,706	578	0	189	0	3,472
2015 HKD'000
3SBio Inc.	FD, VP	2015-12-31	1,071	549		190		1,810
Total			1,071	549	0	190	0	1,810

These data are incomplete. They are entered and checked by volunteers, so if you want to expand them then volunteer to be a Webb-site editor and add pay records from annual reports! Please report any errors.
If a director sits on the boards of both a listed company and its listed subsidiary, then the parent company records will normally include the pay at the subsidiary, so you should subtract that when looking at annual totals.